Mechanism
Human GLP-1 analog with a single amino-acid substitution (Lys34→Arg) and a C16 palmitoyl fatty acid attached to Lys26 via a glutamate linker, producing a long-acting GLP-1 receptor agonist.6880
Peptide record
Human GLP-1 analog with a single amino-acid substitution (Lys34→Arg) and a C16 palmitoyl fatty acid attached to Lys26 via a glutamate linker, producing a long-acting GLP-1 receptor agonist.6880
Approved for type 2 diabetes and weight management, improving glycemic control and inducing weight loss through GLP-1–mediated insulinotropic, glucagonostatic, and appetite-suppressing actions.6880
GLP-1(7–37) analog with 97% sequence homology to native GLP-1, incorporating Lys34Arg and a C16 acyl chain on Lys26; 31 amino acids.68
31 amino acids
GCG